PFENNIGER RICHARD C JR 4

What Happened
Richard C. Pfenniger Jr., a director of OPKO Health, Inc. (OPK), was granted an award for 60,000 shares on June 18, 2026. The Form 4 reports the acquisition as a derivative award at $0.00 per share (total reported cash consideration $0). This is an acquisition/award rather than a sale.

Key Details

• Transaction date: 2026-06-18 (reported on Form 4 filed 2026-06-22). Filing appears timely (within the two-business-day window).
• Transaction type/code: Grant/Award (A) — reported as a derivative acquisition.
• Shares involved: 60,000 shares; price reported: $0.00; total cash consideration reported: $0.
• Shares owned after transaction: not specified in this Form 4.
• No 10b5-1 plan, tax withholding, or other footnotes are listed on the reported transaction.

Context
The filing records a grant of derivative securities (commonly restricted stock or RSUs, though the Form 4 does not specify the instrument or vesting terms). Awards like this are typically part of compensation or board grants and represent an insider acquisition rather than a sale; investors may view insider purchases/awards as more informative than sales, but the filing itself does not state the insider’s motivation. For full details (vesting schedule or grant agreement), check OPKO’s proxy statements or subsequent disclosures.